Aprea Therapeutics, Inc.
APRE • NASDAQ
Aprea Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Oren Gilad, with a market cap of $8.4M.
Market Cap$8.4M
Employees7.0
CEOOren Gilad
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Aprea Therapeutics, Inc. FAQ
Common questions about Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 13, 2026.
Aprea Therapeutics, Inc. has approximately 7 employees.